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The Validity, Reliability, Measurement Error, and Minimum
Detectable Change of the 30-Second Fast-Paced Walk Test
in Persons with Knee Osteoarthritis: A Novel Test of
Short-Distance Walking Ability
Lisa T. Hoglund,1

Eric Folkins,2 Laura Pontiggia,2 and Michael W. Knapp2

Objective. To develop and establish the reliability, validity, measurement error, and minimum detectable change
of a novel 30‐second fast‐paced walk test (30SFW) in persons with knee osteoarthritis (OA) that is easy to administer
and can quantify walking performance in persons of all abilities.
Methods. Twenty females with symptomatic knee OA (mean age [SD] 58.30 [8.05] years) and 20 age‐ and sex‐
matched asymptomatic controls (57.25 [8.71] years) participated in the study. Participants completed questionnaires
of demographic and clinical data, the Knee Injury and Osteoarthritis Outcome Score (KOOS), and the 36‐item Short
Form Health Survey (SF‐36) followed by 30SFW performance. Participants returned 2‐7 days later and performed the
30SFW again.
Results. The knee OA group reported function that was worse than controls (all KOOS subscales; P < 0.0001).
The 30SFW intrarater and interrater reliability were excellent [ICC(2,1) = 0.95‐0.99]. Knee OA participants walked a
shorter distance in the 30SFW than controls (mean [SD]: OA 44.4 m [9.5 m]; control 58.1 m [7.8 m]; P < 0.0001).
Positive strong correlations were found between the 30SFW and the KOOS–Activity of Daily Living, SF‐36‐Physical
Functioning, and SF‐36‐Physical Health Composite scores (P < 0.0001). A nonsignificant, weak correlation between
30SFW and SF‐36‐Mental Health scores was present (r = 0.32, P = 0.05).
Conclusion. The 30SFW has excellent intrarater and interrater reliability. The 30SFW demonstrated excellent
known groups, convergent, and discriminant validity as a measure of short‐distance walking ability in persons with
knee OA. Clinicians and researchers should consider using the 30SFW to quantify walking ability in persons with knee
OA and assess walking ability change.
INTRODUCTION
Knee osteoarthritis (OA) is a growing public health problem
and a leading contributor to disability worldwide (1). Approximately
14 million adults in the United States have symptomatic knee OA,
which is a cause of pain, reduced walking ability, and participation restriction (2,3). The presence of symptomatic knee or hip
OA was the strongest contributor to self‐reported walking difficulty
of all chronic health conditions in adults 55 years or younger (4).
Reduced walking ability is proposed to cause reduced physical
activity, which is a risk factor for death that is due to cardiovascular
disease (5–7).
Because reduced walking ability may result in disability
and early mortality, it is critical that health care providers and
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College of Health Professions Dean's Research Award, Thomas Jefferson University.
Lisa T. Hoglund, PhD, BS: Thomas Jefferson University, Philadelphia,
Pennsylvania; Eric Folkins, DPT, BS, Laura Pontiggia, PhD, MS, Michael W. Knapp,
DPT, BA: University of the Sciences in Philadelphia, Philadelphia, Pennsylvania.

researchers have valid, reliable, and easily administered outcome measures of walking ability. Although patient‐reported
outcome measures for physical function are available, patient‐
reported results for walking ability are determined predominantly
by pain intensity rather than physical walking performance (8,9).
Measurement of actual walking ability with reliable, valid physical
performance measures (PPMs) is critical to quantitatively assess
walking ability in persons with knee OA. Currently, there is no
PPM of walking ability that is reliable and valid in persons with
knee OA across the spectrum of pain severity (10,11).
Current PPMs for short‐distance walking are based on time
to walk a set distance and cannot be used by those unable to
complete the required distance (floor effect) (12). Importantly,
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SIGNIFICANCE & INNOVATIONS

• Symptomatic knee osteoarthritis (OA) is one of the
strongest contributors to reduced walking ability, a
cause of reduced physical activity, and participation
restriction. Therefore, it is vital that clinicians and
researchers have valid and reliable physical performance measures (PPMs) of walking ability for persons with knee OA that do not require large time or
space requirements.
• This study shows that the 30-second fast-paced
walk test (30SFW) is a reliable and valid measure
of short-distance walking ability in persons with
knee OA. The 30SFW is the first PPM to evaluate
short-distance walking ability with evidence for
both reliability and validity as well as minimum detectable change.
• The 30SFW is feasible for use in clinical, research,
and community settings to quantify walking ability
for persons with knee OA. This PPM requires minimal time, space, and special equipment.

current PPMs for walking distance are difficult to conduct in
clinical settings because of the requirement for straight, unobstructed walkways of 20 m or more in length (12). The Osteoarthritis Research Society International (OARSI) recommended
that a PPM of short‐distance walking based on time be developed and validated for persons with knee OA (12). Such a PPM
would be useful as a measure of an individual’s walking ability
and to assess response to interventions. The objective of this
study was to develop and establish the reliability, validity, measurement error, and minimum detectable change (MDC) of a novel
30‐second fast‐paced walk test (30SFW) for persons with knee
OA that is easy to administer and can quantify walking performance in persons of all abilities. We hypothesized that 1) the
30SFW would demonstrate excellent intrarater (test‐retest) and
interrater reliability evidenced by an intraclass correlation coefficient (ICC) that is 0.91 or greater; 2) that the 30SFW would
demonstrate convergent construct validity evidenced by strong
correlations (r ≥ 0.60) between 30SFW scores and patient‐
reported physical function scores; 3) that the 30SFW would
demonstrate discriminant construct validity evidenced by weak
correlations (r ≤ 0.39) between 30SFW and a patient‐reported
mental health score; and 4) that the 30SFW would demonstrate
known groups construct validity evidenced by a significant difference (P < 0.05) in scores on the 30SFW between knee OA and
asymptomatic control groups (13).

METHODS
Participants. Twenty participants with symptomatic knee
OA and 20 age‐ and sex‐matched asymptomatic control subjects participated in the study. An a priori power analysis based
on ICC2,1 for intrarater and interrater reliability indicated that a
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minimum of 16 participants were required in order to achieve an
optimal ICC of 0.91 and a minimally acceptable level of reliability
of 0.70 at the 0.05 significance level and power of 0.80. For the
validity analysis, a minimum of 15 participants were required in
order to achieve a Pearson correlation coefficient of 0.85 and a
minimally acceptable correlation of 0.5 at a significance level of
0.05 and power 0.80. In order to account for potential dropouts,
20 participants with knee OA and 20 asymptomatic control participants were recruited (Table 1). Inclusion criteria for the knee
OA group were as follows: age 40‐75 years, self‐reported physician’s diagnosis of knee OA, knee pain in one or both knees most
days of the month for at least one month in the previous year, and
the ability to walk without an assistive device. Inclusion criteria for
the control group were as follows: age 40‐75 years, no physician‐diagnosed knee OA, no reported knee pain on most days
of the month for 1 month in the previous year, and the ability to
walk without an assistive device. Exclusion criteria for both groups
included pregnancy, known OA of other lower‐extremity joints,
history of lower‐extremity arthroplasty or osteotomy, other neuromusculoskeletal or systemic conditions that may cause knee pain
or limit walking performance, knee injections within the previous
30 days, and any medical or physical condition that would make
walking quickly contraindicated. Participants were recruited from
the Thomas Jefferson University (TJU) Hospital and Mercy Fitzgerald Hospital physical therapy clinics as well as through advertisements at TJU and the University of the Sciences in Philadelphia.
The study was approved by the Institutional Review Boards of the
University of the Sciences, Mercy Fitzgerald Hospital, and TJU.
The research was performed in accordance with the Declaration
of Helsinki, and all participants signed a written informed consent
prior to inclusion in the study.
Patient-reported outcome measures. Construct validity testing was performed by comparing 30SFW scores to participant scores on three subscales of two patient‐reported outcome
measures (PROMs). The Knee Injury and Osteoarthritis Outcome
Score (KOOS) is a knee‐region–specific PROM for use with persons with knee OA or injuries that may cause knee OA (meniscal
or anterior cruciate ligament tears, etc) (14). The KOOS has five
subscales, including the Activity of Daily Living (ADL) subscale
(KOOS‐ADL); each subscale is scored out of 100, and higher
scores indicate better status. The KOOS has been shown to be
reliable and valid to assess health status in persons with knee OA
(15).
The Rand Medical Outcomes Study 36‐item Short Form
Health Survey (SF‐36) is a general quality‐of‐life PROM with eight
subscales, including physical functioning (SF‐36‐PF) and mental
health (SF‐36‐MH) subscales (16). A Physical Health Composite Summary score of the SF‐36 (SF‐36‐PHC) can be calculated
using scores from four subscales (physical functioning, role limitations due to physical health, bodily pain, and general health) (17).
The SF‐36 has been shown to be reliable and valid as a measure
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Table 1.

3

Demographic characteristics of participants
Descriptor

OA (n = 20)

Control
(n = 20)

P Valuea

Age, y
Mean ± SD
Range

58.30 ± 8.05

57.25 ± 8.71

44-72

44-74

0.63b

Race
African American/Black
Asian
Caucasian
Average pain

5 (25.00%)

0 (0%)

1 (5.00%)

10 (50.00%)

14 (70.00%)

5 (3, 7)

0 (0, 0)

<0.0001e

0 (0, 0)

<0.0001e

0.19c

d

Median (IQR)
Current pain

10 (50.00%)

d

Median (IQR)

4.5 (1, 6)

Abbreviation: IQR, interquartile range; OA, osteoarthritis
a
All P values are two-sided; bP value from two-sample t test; cP value from Fisher’s exact test;
d
Numeric pain rating, 0-10 with 0 = no pain and 10 = maximal pain; eP value from Wilcoxon
rank-sum test.

of quality of life and perceived function in persons with knee OA
(18,19). Each subscale and composite summary score is scored
out of 100, with higher scores indicating better status.
Study instrument and procedure. Six physical therapists and one physical therapist assistant conducted all tests
and were trained in the procedure by the principal investigator.
After signing the written consent form, participants completed
questionnaires of demographic and clinical data, the KOOS, and
the SF‐36. Participants then performed the 30SFW test, in which
examiners used a standardized script of verbal instructions. Participants stood with the front of their shoes on a starting line and
were instructed as follows: “Walk the farthest distance you can
by walking at a fast, but safe, speed for 30 seconds. I will tell
you when to begin and keep walking until I say ‘Stop.’ To tell
you when to begin, I will count down from 3. Are you ready?
3‐2‐1‐Go!” Participants performed one practice trial at a moderate pace; two scored trials at a fast pace were performed with a
5‐minute rest between scored trials. Participants rated any knee
pain before and after each scored trial with a numeric pain rating
(0‐10, 0 = no pain, 10 = maximal pain). The numeric pain rating
scale has been found to be a valid and reliable measure of pain
intensity in adults with arthritis (20). The distance walked in 30
seconds was measured with a measuring wheel from the starting line to the front of the foot that was in contact with the ground
at 30 seconds and was farthest from the start. The 30SFW test
result was the greater distance walked of the two scored trials.
Participants returned 2‐7 days following the first session and
performed the 30SFW according to the same procedure and
with the same examiner as at the first session. A second examiner measured the distance walked in each scored trial at one of
the two test sessions.

Statistical analysis. The Rand SF‐36 subscale and composite summary scores were calculated with custom formulas in
an Excel (Microsoft) spreadsheet and are available in an appendix
to an article by Laucis et al (17). Descriptive statistics were used
to summarize demographic characteristics, pain measurements,
KOOS scores, and SF‐36 scores. Qualitative data were reported
as percentages and numeric counts; quantitative data as means
± SD or median and interquartile range (IQR). Comparisons
between groups were performed using Student’s t tests if the data
were normally distributed based on the Shapiro‐Wilk test or by
using the Wilcoxon rank‐sum test if otherwise. Intrarater and interrater reliability were assessed using ICC2,1 (21). Measurement error
was assessed as the
√ standard error of measurement (SEM) and
calculated as SD × 1 − ICC (21). The MDC was calculated at √
the
95% confidence level (MDC95) with the formula SEM × 1.96 × 2
. Convergent and discriminant construct validity were examined
using Pearson’s correlation coefficient and were evaluated using
the guidelines by Evans (correlation levels: negligible = 0.00‐0.19,
weak = 0.20‐0.39, moderate = 0.40‐0.59, strong = 0.60‐0.79,
very strong = 0.80‐1.00) (22).
Convergent validity was assessed by the presence of a
hypothesized r ≥ 0.60 between the 30SFW test score and scores
on the KOOS‐ADL, the SF‐36‐PF, and the SF‐36‐PHC (13). Discriminant validity was assessed by the presence of a hypothesized r ≤ 0.39 between the 30SFW score and the score on the
SF‐36‐MH (13). Known group validity was assessed by comparison of the 30SFW scores between groups with Student’s t tests,
2‐tailed, P < 0.05 (13). All statistical analyses were conducted
using SAS software v.9.4 (SAS Institute Inc).
Post hoc analysis to calculate gait speed in meters per second was performed to enable comparison of study findings to
previous research.
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Table 2.

Baseline KOOS subscale scores
Descriptor

OA (n = 20)

Control (n = 20)

P Valuea,b

59.72 (38.89, 72.22)

100 (100, 100)

<0.0001

62.50 (48.21, 73.21)

100 (96.43, 100)

<0.0001

63.24 (42.65, 88.24)

100 (100, 100)

<0.0001

37.5 (25, 50)

100 (100, 100)

<0.0001

43.75 (31.25, 62.5)

100 (100, 100)

<0.0001

KOOS Pain
Median (IQR)
KOOS Symptoms
Median (IQR)
KOOS Activity of Daily Living
Median (IQR)
KOOS Sport/Recreation
Median (IQR)
KOOS Quality of Life
Median (IQR)

Abbreviation: IQR, interquartile range; KOOS, Knee Injury and Osteoarthritis Outcome Score;
OA, osteoarthritis.
a
All P values are two-sided; bP value from Wilcoxon rank-sum test.

RESULTS
Participant characteristics. Baseline characteristics
showed no significant difference between knee OA and control
groups with respect to age or race (P > 0.05) (Table 1). The knee
OA group had a significantly greater baseline average and current pain compared with the control group (P < 0.05) (Table 1).
Table 3.

The knee OA group showed significantly lower scores in all KOOS
measures (P < 0.05) (Table 2) and SF‐36 scores except for SF‐36
Role Function – Emotional and SF‐36‐MH (P = 0.17 and P = 0.49,
respectively) (Table 3).
Reliability and measurement error. Intrarater (test‐
retest, between sessions) and interrater (within session) reliability

Baseline SF‐36 subscale scores
Descriptor

OA (n = 20)

Control (n = 20)

P Valuea,b

55 (35, 80)

100 (97.5, 100)

<0.0001

62.5 (0, 100)

100 (100, 100)

<0.0001

100 (83.33, 100)

100 (100, 100)

0.17

55 (37.5, 65)

80 (65, 85)

0.0009

84 (68, 92)

86 (78, 92)

0.49

75 (62.50, 100)

100 (100, 100)

0.003

57.5 (33.75, 78.75)

90 (90, 100)

<0.0001

67.5 (60, 77.5)

90 (82.5, 95)

0.0001

43.97 (33.11, 52.13)

59.52 (55.86, 61.04)

<0.0001

49.23 (43.31, 58.56)

57.22 (53.98, 60.52)

0.008

SF-36 Physical Functioning
Median (IQR)
SF-36 Role Function
- Physical
Median (IQR)
SF-36 Role Function
- Emotional
Median (IQR)
SF-36 Energy
Median (IQR)
SF-36 Mental Health
Median (IQR)
SF-36 Social Functioning
Median (IQR)
SF-36 Pain
Median (IQR)
SF-36 General Health
Median (IQR)
SF-36 Physical Health
Composite
Median (IQR)
SF-36 Mental Health
Composite
Median (IQR)

Abbreviation: IQR, interquartile range; OA, osteoarthritis; SF-36 = 36-item Short Form Health
Survey. aAll P values are two-sided; bP value from Wilcoxon rank-sum test.

|

THIRTY‐SECOND FAST‐PACED WALK TEST

5

Table 4. Indicators for interrater and intrarater reliability (ICC2,1), standard error of measurement, and minimum detectable change
Descriptor

Interrater ICC(2,1)
(95% CI)

Interrater
SEM (m)

Interrater
MDC.95 (m)

Intrarater ICC(2,1)
(95% CI)

Intrarater
SEM (m)

Intrarater
MDC.95 (m)

Overall

0.99 (0.99, 1.00)

0.29

0.80

0.97 (0.94, 0.99)

1.87

5.17

OA

0.99 (0.99, 1.00)

0.29

0.82

0.96 (0.87, 0.98)

2.05

5.67

Control

0.99 (0.99, 1.00)

0.28

0.79

0.95 (0.89, 0.98)

1.66

4.61

Abbreviation: CI, confidence interval; MDC, minimum detectable change; OA, osteoarthritis; SEM, standard error of measurement.

of the 30SFW test was examined with ICC2,1. The results ranged
from r = 0.95 to r = 0.99 and were found to be excellent. Table 4
presents ICC2,1 values with 95% confidence intervals, SEM, and
MDC95 values.
Convergent and discriminant validity. As hypothesized, there were significant strong positive correlations between
the 30SFW test and the KOOS‐ADL, SF‐36‐PF, and SF‐36‐PHC
scores (P < 0.05) (Table 5). As hypothesized, the correlation
between the 30SFW test and the SF‐36‐MH score was nonsignificant and weak (r = 0.32, P = 0.05) (Table 5).
Known groups validity. As hypothesized, the knee OA
group walked a significantly shorter distance in the 30SFW compared with the control group (P < 0.0001) (Table 6). A very large
effect size was found between the two groups (Cohen’s d [95%
CI], session 1: −1.58 [−2.29, −0.87]; session 2: −1.46 [−2.16,
−0.76]), indicating a large negative effect of knee OA on distance
walked in the 30SFW (Table 6). Prewalk and postwalk numeric
pain ratings were significantly higher in the knee OA group than
in the control group (P < 0.0001). However, the knee OA group
prewalk to postwalk pain rating change was not significant (P >
0.05) (Table 6).

Post hoc analysis. Distance walked in the 30SFW at session one was divided by 30 seconds to determine gait speed. The
mean (SD) gait speed for the knee OA group was 1.48 (0.32) m/s
compared with 1.94 (0.26) m/s for the control group, which were
significantly different (independent t test, 2‐tailed, P < 0.0001). A
very large effect size was found between the two groups (Cohen’s
d [95% CI], −1.58 [−2.29, −0.87]), indicating a large negative
effect of knee OA on gait speed.

DISCUSSION
This study examined the 30SFW, a novel PPM of walking
ability, in persons with knee OA compared with an asymptomatic control group. As hypothesized, the 30SFW had excellent
interrater and intrarater (test‐retest) reliability for persons with
knee OA as well as asymptomatic individuals. Our hypotheses
that the 30SFW as a test of walking performance would demonstrate excellent convergent, discriminant, and known groups
construct validity were also supported. In addition, very large
effect sizes were found for distance walked in the 30SFW and
for gait speed, indicating that the presence of knee OA had
a very large effect on distance walked and gait speed in the
30SFW (23).

Table 5. Thirty‐second fast‐walk test correlation analysis with patient-reported outcome
measures
Pearson
Correlation

95% Confidence
Interval

KOOS-ADL

r = 0.70

(0.50, 0.83)

<0.0001

SF-36 Physical Functioning

r = 0.69

(0.48, 0.82)

<0.0001

SF-36 Role Function - Physical

r = 0.60

(0.35, 0.77)

<0.0001

SF-36 Role Function - Emotional

r = 0.37

(0.07, 0.61)

0.02

SF-36 Energy

r = 0.55

(0.29, 0.74)

0.0002

SF-36 Mental Health

r = 0.32

(0.006, 0.57)

0.05

SF-36 Social Functioning

r = 0.51

(0.23, 0.71)

0.0009

SF-36 Pain

r = 0.69

(0.48, 0.82)

<0.0001

SF-36 General Health

r = 0.61

(0.37, 0.77)

<0.0001

SF-36 Physical Health Composite

r = 0.73

(0.55, 0.85)

<0.0001

SF-36 Mental Health Composite

r = 0.54

(0.27, 0.73)

0.0004

Patient-Reported Outcome Measure

P Valuea

Abbreviation: KOOS-ADL, Knee Injury and Osteoarthritis Outcome Score – Activity of Daily Living
subscale; SF-36 = 36-item Short Form Health Survey.
a
All P values are two-sided.
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Table 6.

Pain and distance walked measurements
Descriptor

Control
(n = 20)

OA (n = 20)

P Valuea

Session 1
Prewalk NPR Median (IQR)

1.5 (0, 5.5)

0 (0, 0)

<0.0001b

Postwalk NPR Median (IQR)

1 (0, 4)

0 (0, 0)

<0.0001b

Post-Prewalk NPR Change
Median (IQR)

0 (0, 0)

0 (0, 0)

0.65b

Post-Prewalk NPR Change
Within-group P value

P = 1.00c

…

…

Distance (m) mean ± SD

44.37 ± 9.46

58.06 ± 7.80

<0.0001d

Distance effect size – Cohen's d
(95% CI)

−1.58 (−2.29,
−0.87)

Session 2
Prewalk NPR Median (IQR)

1 (1, 4.5)

0 (0, 0)

<0.0001b

Postwalk NPR Median (IQR)

1 (0, 3.5)

0 (0, 0)

<0.0001b

Post-Prewalk NPR Change
Median (IQR)

0 (0, 0)

0 (0, 0)

0.65b

Post-Prewalk NPR Change
Within-group P value

P = 0.81c

Distance (m) mean ± SD

45.80 ± 9.88

58.74 ± 7.71

<0.0001d

Distance effect size – Cohen's d
(95% CI)

−1.46 (−2.16,
−0.76)

Abbreviation: CI, confidence interval; IQR, interquartile range; NPR, numeric pain rating; OA,
osteoarthritis;
a
All P values are two‐sided; bP value from Wilcoxon rank‐sum test (between groups comparison);
c
P value from Wilcoxon signed rank test; dP value from Student’s t test.

Reliability of walking performance of persons with knee OA is
reported to be better for tests of fast‐paced walking compared with
usual‐paced walking (24). A systematic review of PPMs for persons with knee and hip OA reported that there is limited evidence
for reliability and measurement error for PPM of fast‐paced walking
(10). There was limited evidence for intrarater and interrater reliability for a 50‐ft fast‐paced walk test and for a 40‐m fast‐paced walk
test for mixed populations of hip and knee OA participants who
were awaiting total joint replacement (10,25,26). Current OARSI
recommendations for a test of short‐distance walking ability for
persons with knee and hip OA is the 40‐m fast‐paced walk test,
based on expert opinion, limited measurement property evidence,
and feasibility of conducting this walk test (12). More recently, the
reliability of the 40‐m fast‐paced walk test has been established
for a mixed population of persons with knee and hip OA as well as
a population of persons preceding total joint arthroplasty for knee
OA (11,27). The reliability values for the 30SFW in the current study
are higher than those reported for the 40‐m fast‐paced walk test
(intrarater ICC = 0.92‐0.93, interrater ICC = 0.96), yet both studies
have excellent reliability (11,27). The higher interrater and intrarater
reliability for the 30SFW may be due to differing test procedures.
The 40‐m fast‐paced walk test procedure requires frequent start-

ing and stopping of a stopwatch as participants walk beyond endpoints of a 10‐m walkway, turn, and walk back across the walkway
for a total of four repetitions. This requires an examiner to start or
stop a stopwatch a total of eight times during the timed test, which
may be a source of examiner error (28). Additional differing reliability results may be due to differing patient populations. The 30SFW
was tested in a population of persons with symptomatic knee OA
who were attending physical therapy or who were recruited from
nonsurgical physician practices or from the community. The 40‐m
fast‐paced walk test was examined in populations of persons at
end‐stage OA who were awaiting joint replacement, from a mixed
population of persons with knee and hip OA, and a population of
persons with end‐stage knee OA (11,26,27).
To our knowledge, the current study is the first to report construct validity for a PPM of short‐distance walking ability for persons
with knee OA, reported to be an important construct to measure
for persons with knee and hip OA (12). In addition to excellent convergent, discriminant, and known groups validity, the 30SFW test
met 100% of the study hypotheses, demonstrating hypotheses
testing construct validity. The systematic review of psychometric
properties of PPM for knee and hip OA did not locate any studies
with evidence of validity for short‐distance walk tests (10). Gill et al
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(13) examined the validity of several PPMs and PROMs in persons
awaiting knee or hip joint replacement for OA. A 50‐foot fast‐paced
walk test was found to have evidence for convergent validity that
was due to moderate to high significant correlations with scores on
the 30‐second chair stand test, the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)‐Function subscale,
SF‐36‐PF, SF‐36‐PHC, and Patient Specific Functional Scale
(Spearman rho, P < 0.01 for all, ρ = −0.64, ρ = 0.42, ρ = −0.39, ρ =
−0.38, ρ = −0.36, respectively). In the same study, there was also
evidence of discriminant validity for the 50‐foot fast‐paced walk test
that was due to nonsignificant weak association with the SF‐36‐
MH (Spearman rho, ρ = −0.12, P > 0.05) (13). Evidence for known
groups validity was reported due to significant differences between
participants who required an assistive gait aid versus those who
ambulated without an assistive device (independent t test, P <
0.001) (13). The results of the 30SFW test in the current study were
similar to those found for the 50‐foot fast‐paced walk test for discriminant and known groups validity tests. However, for convergent
validity testing, the correlations between 30SFW scores and the
KOOS‐ADL, SF‐36‐PF, and SF‐36‐PHC scores were all stronger
than the correlations reported for convergent validity for the 50‐foot
fast‐paced walk test. Interpreting magnitude of correlation is somewhat arbitrary (22), but the correlation levels reported by Gill et al
(13) for their walk test would have been considered weak for the
SF‐36‐PF, SF‐36‐PHC, and the Patient Specific Functional Scale
according to levels proposed by Evans (22). Differing findings for
convergent validity between our study and the study by Gill et al
(13) may have been due to different test procedures and different
patient populations. Participants in the study by Gill et al (13) were a
mix of females and males (63% female), the average age was older
than that of our participants (mean = 70.3 years [SD 9.8 years]), it
contained a mix of persons with knee or hip OA, and the severity
of OA was likely worse than that of our participants because they
studied persons awaiting joint replacement surgery. More recently,
the study by Tolk et al (11) reported that the 40‐m fast‐paced walk
test did not meet the required level of 75% hypotheses test confirmation and thus did not demonstrate construct validity for walking
ability (4 of 15 [27%] predefined hypotheses achieved) (11). Different findings for validity between the study by Tolk et al (11) and
the current study may have been due to different test procedures,
different participant sex (57% female in the earlier study), the older
age of their participants (mean = 69.3 years [SD 8.2 years]), and
that their participants were all awaiting joint replacement and thus
were more likely to have severe knee OA.
Post hoc calculation of gait speed for participants in the
current study was performed in order to allow comparison with
previous studies that were anchored on distance. Participants
in the current study walked faster than those in previous studies
that examined gait speed for persons with knee or hip OA when
walking 40 m or 50 ft (11,13,25,26). The difference in gait speed
between studies may be due to the older average age of participants in previous studies, the fact that participants in previous
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studies were awaiting joint replacement so likely had more severe
OA, the mixed samples of persons with knee and hip OA in previous studies, and different test procedures.
The 30SFW was found to be a reliable and valid PPM of
short‐distance walking ability in persons with knee OA. This
novel PPM is feasible for use in research, in clinical settings,
and in the community to quantify actual physical function. Minimal equipment is required; only a course, a stopwatch or timer,
a measuring wheel, and tape or cones to mark the course are
necessary. The course does not need to be an unobstructed
15‐20 m walkway as required by previous PPMs of short‐distance walking ability. This is important because smaller clinics, research labs, and community settings may not have this
length of unobstructed walkway available. The course can be
rectangular or oblong in shape and should not contain turns
greater than a 90° angle so that participants do not need to
slow down when making a turn. The time to conduct the test
is short, making this feasible for busy clinicians and researchers. The time required to perform the 30SFW is the same as
the time required to perform the 30‐second chair stand test,
one of the PPMs recommended by OARSI for use with persons with knee or hip OA (12). Using the reported MDC95 for
distance walked on the 30SFW, clinicians and researchers can
determine if true change has occurred for a patient or research
subject, that is, a difference greater than measurement error.
This study has several limitations that must be considered. The sample size was small and no participants used
assistive devices. Examiners were not blinded to participant
group. Although it was not intended to be a study of only
females, potential knee OA participants who met all study criteria were all female. We did not require diagnostic imaging
and so are unable to comment on the radiographic degree
of OA for study participants. Future research should examine
psychometric properties of the 30SFW in males, those who
use assistive devices during ambulation, those who have different pathologies, responsiveness, and determination of the
minimum clinically important difference.
In conclusion, our findings show that the 30SFW is a reliable, valid measure of short‐distance walking ability in persons
with knee OA. It is the first PPM to measure this construct with
evidence for both reliability and validity. It is feasible for use in
clinics, research laboratories, and in the community, requiring
little time, space, or special equipment. Clinicians and researchers should consider using the 30SFW to quantify walking ability
of patients and research subjects as well as to determine if true
change or difference is present.
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